The gut plays a crucial role in determining our overall health and how we respond to medical treatments. It is home to a vast array of microorganisms, collectively known as the gut microbiota, which number in the trillions. Research has established the crucial role that these microorganisms play in maintaining gut health, and their impact on conditions, such as cancer, is now widely recognized. But how can we use the gut microbiota to predict and prevent colorectal cancer?
Dr. Doratha A. Byrd, an assistant member in Moffitt Cancer Center’s Cancer Epidemiology Program, focuses her research on the interrelationships among modifiable dietary and lifestyle exposures, the microbiome, and cancer risk and progression. She’s focused on using multilevel approaches to address cancer disparities within microbiome research.
Click to read more.